Blog
Product strategy, conversion systems, and telehealth operations for teams building modern care journeys.
Starting a GLP-1 Telehealth Business in Late 2026: What Still Works After Compounding
Is it too late to start a GLP-1 telehealth business? Too late for the 2024 version, where a $99 compounded vial and a Facebook ad account made a company. Not too late for the version that is actually working in the third quarter of 2026: a niche, a retention system, branded drugs the manufacturer ships, and fixed costs low enough that 500 patients is a business. Here is what died, what the numbers say still works, and the three things that now count as a moat.
Instagram Ads for GLP-1 Programs: What Actually Works (Without Getting Restricted)
A practical, operator-focused playbook for running Instagram ads for GLP-1 programs (semaglutide, tirzepatide, Ozempic, Wegovy) while staying compliant and improving conversions.
Marketing Your GLP-1 Program in 2026: A Founder’s Playbook to Stand Out
A practical, founder-style guide to marketing a GLP-1 telehealth program (Ozempic®, Wegovy®, semaglutide) with better conversion, lower CAC, and fewer operational headaches.
Building a Successful GLP-1 Program: Lessons from the Field
Discover proven strategies for launching and scaling a GLP-1 weight management program based on real-world experience.
How to Launch a GLP-1 Telehealth Program (Ozempic, Wegovy, Semaglutide)
A comprehensive guide to launching your own GLP-1 weight management telehealth program, from regulatory requirements to patient acquisition.